- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Phaxiam Therapeutics SA (0QSS)
Phaxiam Therapeutics SA stock price live, this page displays EPA PHXM stock exchange data. View the PHXM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Phaxiam Therapeutics SA real time stock price chart below.
What Is the Phaxiam Therapeutics SA Stock Price Today?
The Phaxiam Therapeutics SA stock price today is 0.10.
What Is the Stock Symbol for Phaxiam Therapeutics SA?
The stock symbol for Phaxiam Therapeutics SA is ""PHXM.""
What Stock Exchange Does Phaxiam Therapeutics SA Trade On?
Phaxiam Therapeutics SA is listed and trades on the Paris stock exchange.
Is Phaxiam Therapeutics SA a Good Stock to Buy?
Determining whether Phaxiam Therapeutics SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PHXM quote. (ISIN: FR001400K4B1)
What Is the Phaxiam Therapeutics SA Stock Price Today?
The Phaxiam Therapeutics SA stock price today is 0.10.
What Is the Stock Symbol for Phaxiam Therapeutics SA?
The stock symbol for Phaxiam Therapeutics SA is ""PHXM.""
What Stock Exchange Does Phaxiam Therapeutics SA Trade On?
Phaxiam Therapeutics SA is listed and trades on the Paris stock exchange.
Is Phaxiam Therapeutics SA a Good Stock to Buy?
Determining whether Phaxiam Therapeutics SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PHXM quote. (ISIN: FR001400K4B1)
0.10
0.00(0.00%)
Real-time Data·
Fair Value
An estimate of a Phaxiam Therapeutics SA's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.10
0.12
52 wk Range
0.03
2.10
0QSS Scorecard
Full Analysis
Trading at a low Price / Book multiple
0QSS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Phaxiam Therapeutics SA's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.100.12
52 wk Range
0.032.10
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
0QSS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Phaxiam Therapeutics SA's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Phaxiam Therapeutics SA Company Profile
PHAXIAM Therapeutics S.A., a clinical-stage biopharmaceutical company, focuses on developing bacteriophage-based therapies for severe resistance infections in France. The company develops and commercializes red cell-based therapies for cancers and orphan diseases. It develops anti-infectious therapies based on the use of bacteriophages (phages) to treat infections caused by Escherichia coli (E.coli), Pseudomonas aeruginosa (P.aeruginosa), and Staphylococcus aureus (S.aureus). The company was formerly known as ERYTECH Pharma S.A. and changed its name to PHAXIAM Therapeutics S.A. in June 2023. The company was incorporated in 2004 and is headquartered in Lyon, France.
Compare 0QSS to Peers and Sector
Metrics to compare | 0QSS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship0QSSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −2.2x | −0.5x | |
PEG Ratio | - | 0.02 | 0.00 | |
Price/Book | 0.0x | 1.6x | 2.6x | |
Price / LTM Sales | 0.5x | 3.9x | 3.3x | |
Upside (Analyst Target) | - | 134.8% | 43.5% | |
Fair Value Upside | Unlock | 17.0% | 6.9% | Unlock |
Earnings
Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Phaxiam Therapeutics SA Trade On?
Phaxiam Therapeutics SA is listed and trades on the London Stock Exchange stock exchange.
What Is the Stock Symbol for Phaxiam Therapeutics SA?
The stock symbol for Phaxiam Therapeutics SA is "0QSS."
What Is the Phaxiam Therapeutics SA Market Cap?
As of today, Phaxiam Therapeutics SA market cap is 1.01M.
What Is Phaxiam Therapeutics SA's Earnings Per Share (TTM)?
The Phaxiam Therapeutics SA EPS (TTM) is 0.00.
When Is the Next Phaxiam Therapeutics SA Earnings Date?
Phaxiam Therapeutics SA will release its next earnings report on 23 Sept 2025.
From a Technical Analysis Perspective, Is 0QSS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Phaxiam Therapeutics SA Stock Split?
Phaxiam Therapeutics SA has split 0 times.
How Many Employees Does Phaxiam Therapeutics SA Have?
Phaxiam Therapeutics SA has 68 employees.
What is the current trading status of Phaxiam Therapeutics SA (0QSS)?
As of 07 Aug 2025, Phaxiam Therapeutics SA (0QSS) is trading at a price of 0.10, with a previous close of 0.00. The stock has fluctuated within a day range of 0.10 to 0.12, while its 52-week range spans from 0.03 to 2.10.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.